08 May 2024 INVION SIGNS COLLABORATION AGREEMENT WITH MAJOR SOUTH KOREAN PHARMACEUTICAL GROUP HANLIM FOR THE TREATMENT OF GLIOBLASTOMA 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post